title: What's in the literature?
abstract: In amyotrophic lateral sclerosis (ALS), a recent double-blind placebo-controlled trial of acetyl-L-carnitine along with riluzole showed probable benefit in 42 patients compared with 40 patients who received placebo. Using an electrophysiologic measure devised to differentiate ALS from other neuromuscular conditions, a "splint-hand index" was devised and is reviewed. Analysis of skin in ALS may also be of interest, and there was a report of accumulation of fused in sarcoma protein in the epidermis of ALS patients. With regard to myasthenia gravis, there is another report that early treatment of ocular symptoms with corticosteroids may prevent the development of generalized symptoms. A new study of thymus histopathology in muscle-specific tyrosine kinase (MuSK) myasthenia gravis is covered and another article on the use of thymectomy. In Duchenne muscular dystrophy, the best method of administrating corticosteroids is still being debated, and a long-term study of daily versus intermittent prednisolone is reviewed. The study showed less sustained benefit from the intermittent prednisolone but with a better side effect profile. According to 2 recent reports, it seems that titin mutations may be an underrecognized cause of myopathy with early respiratory failure in adults. Keeping with the respiratory failure theme, there was also an interesting article on the long-term benefits and side effects of cyclosporine in patients with interstitial lung disease from antisynthetase syndrome. Finally, the spectrum of small fiber neuropathy may be expanding to include a causative role in some patients with fibromyalgia syndrome and in juveniles with diffuse pain and a possible autoimmune predisposition.
authors: David
authors: D
authors: Lacomis
authors: Department of Neurology, University of Pittsburgh School of Medicine, UPMC-Presbyterian, Pittsburgh, PA, USA. lacomisd@upmc.edu
authors: Ahmed
authors: A
authors: El-Dokla
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D009135:Muscular Diseases / Q000188:drug therapy; D020388:Muscular Dystrophy, Duchenne / Q000188:drug therapy; D009157:Myasthenia Gravis / Q000628:therapy; D009468:Neuromuscular Diseases